FDA advisors unanimously authorize Johnson & Johnson $JNJ booster

Advisers to the Food and Drug Administration voted unanimously Friday to recommend the agency authorize an extra dose of Johnson & Johnson’s Covid-19 vaccine, to shore up protection against the coronavirus.

The panel of outside doctors and experts voted 19-0 to recommend that all adults who received a first dose of the J&J vaccine should get the second dose at least two months later.

The FDA could decide on whether to clear a J&J booster within days.

J&J Covid-19 Booster Shot Endorsed by FDA Advisers – WSJ